Lotus Pharmaceutical Co., Ltd. announced Name of the previous position holder: Arni Hardarson, Resume of the previous position holder: Representative Director of Lotus Pharmaceutical Co., Ltd. Name of the new position holder: Nat Ativitavas, Resume of the new position holder: Director of Innobic (Asia) Company Limited. Reason for the change: Alvogen Emerging Markets Holdings Limited assigned a new representative director. Effective date of the new appointment: 2023/09/04.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
284 TWD | +2.90% | +1.43% | +4.41% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.41% | 2.31B | |
+40.73% | 739B | |
+32.83% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+15.00% | 240B | |
-5.52% | 206B | |
+6.17% | 164B | |
-0.45% | 162B |
- Stock Market
- Equities
- 1795 Stock
- News Lotus Pharmaceutical Co., Ltd.
- Lotus Pharmaceutical Co., Ltd. Announces Director Changes